Product Pipeline

Cannabis Therapeutics, Inc. is in the development stage of two Cannabinoid-based pharmaceutical drugs and three Cannabinoid-based nutraceutical products

The Cannabinoid-pharmaceutical drugs will be designed to help treat a variety of ailments including - but not limited to - anxiety, depression, triple negative breast cancer, and fatty liver disease.

The research is supported by ETST’s International Application (PCT) for a Provisional Patent named “Cannabidiol Compositions Including Mixtures and Uses Thereof”, which was filed on October 8th, 2015 in regards to its Cannabis Hemp CBD (Cannabidiol) Oil.

The new drugs are compositions for treating cancer, modulating the immune system, and providing neuroprotection against some